Fate Therapeutics' founder to get patent for stem cell method

02/4/2010 | Bloomberg

Fate Therapeutics said Rudolf Jaenisch, one of the firm's founders and a Massachusetts Institute of Technology scientist, will secure a U.S. patent for a technique that can transform cells derived from mammals into stem cells. Fate has an exclusive license to the stem cell method, which also is claimed by two other researchers.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
Director of Actuarial Services, Government Programs
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC